BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38639729)

  • 1. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.
    Gohil SK; Septimus E; Kleinman K; Varma N; Avery TR; Heim L; Rahm R; Cooper WS; Cooper M; McLean LE; Nickolay NG; Weinstein RA; Burgess LH; Coady MH; Rosen E; Sljivo S; Sands KE; Moody J; Vigeant J; Rashid S; Gilbert RF; Smith KN; Carver B; Poland RE; Hickok J; Sturdevant SG; Calderwood MS; Weiland A; Kubiak DW; Reddy S; Neuhauser MM; Srinivasan A; Jernigan JA; Hayden MK; Gowda A; Eibensteiner K; Wolf R; Perlin JB; Platt R; Huang SS
    JAMA; 2024 Jun; 331(23):2007-2017. PubMed ID: 38639729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial.
    Gohil SK; Septimus E; Kleinman K; Varma N; Avery TR; Heim L; Rahm R; Cooper WS; Cooper M; McLean LE; Nickolay NG; Weinstein RA; Burgess LH; Coady MH; Rosen E; Sljivo S; Sands KE; Moody J; Vigeant J; Rashid S; Gilbert RF; Smith KN; Carver B; Poland RE; Hickok J; Sturdevant SG; Calderwood MS; Weiland A; Kubiak DW; Reddy S; Neuhauser MM; Srinivasan A; Jernigan JA; Hayden MK; Gowda A; Eibensteiner K; Wolf R; Perlin JB; Platt R; Huang SS
    JAMA; 2024 Jun; 331(23):2018-2028. PubMed ID: 38639723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial.
    Schweitzer VA; van Heijl I; Boersma WG; Rozemeijer W; Verduin K; Grootenboers MJ; Sankatsing SUC; van der Bij AK; de Bruijn W; Ammerlaan HSM; Overdevest I; Roorda-van der Vegt JMM; Engel-Dettmers EM; Ayuketah-Ekokobe FE; Haeseker MB; Dorigo-Zetsma JW; van der Linden PD; Boel CHE; Oosterheert JJ; van Werkhoven CH; Bonten MJM;
    Lancet Infect Dis; 2022 Feb; 22(2):274-283. PubMed ID: 34627499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a computerized physician order entry (CPOE)-based antibiotic stewardship intervention on the treatment duration for pneumonia and COPD exacerbations.
    Leo F; Bannehr M; Valenta S; Lippeck M; Pachl S; Steib-Bauert M; Semper H; Grohé C
    Respir Med; 2021 Sep; 186():106546. PubMed ID: 34332265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Exposure to High-risk Antibiotics in Acute Care Hospitals With Multidrug-Resistant Organism Burden in Nursing Homes.
    Gontjes KJ; Gibson KE; Lansing BJ; Mantey J; Jones KM; Cassone M; Wang J; Mills JP; Mody L; Patel PK
    JAMA Netw Open; 2022 Feb; 5(2):e2144959. PubMed ID: 35103795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals.
    Anderson DJ; Watson S; Moehring RW; Komarow L; Finnemeyer M; Arias RM; Huvane J; Bova Hill C; Deckard N; Sexton DJ;
    JAMA Netw Open; 2019 Aug; 2(8):e199369. PubMed ID: 31418804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.
    Pettit NN; Nguyen CT; Lew AK; Bhagat PH; Nelson A; Olson G; Ridgway JP; Pho MT; Pagkas-Bather J
    BMC Infect Dis; 2021 Jun; 21(1):516. PubMed ID: 34078301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.
    Gulliford MC; Juszczyk D; Prevost AT; Soames J; McDermott L; Sultana K; Wright M; Fox R; Hay AD; Little P; Moore M; Yardley L; Ashworth M; Charlton J
    Health Technol Assess; 2019 Mar; 23(11):1-70. PubMed ID: 30900550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial.
    Chen JZ; Hoang HL; Yaskina M; Kabbani D; Doucette KE; Smith SW; Lau C; Stewart J; Remtulla S; Zurek K; Schultz M; Koriyama-McKenzie H; Cervera C
    Lancet Infect Dis; 2023 Jun; 23(6):673-682. PubMed ID: 36716763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
    Hellyer TP; Anderson NH; Parker J; Dark P; Van Den Broeck T; Singh S; McMullan R; Agus AM; Emerson LM; Blackwood B; Gossain S; Walsh TS; Perkins GD; Conway Morris A; McAuley DF; Simpson AJ
    Trials; 2016 Jul; 17(1):318. PubMed ID: 27422026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP).
    Deshpande A; Walker R; Schulte R; Pallotta AM; Tereshchenko LG; Hu B; Kadri SS; Klompas M; Rothberg MB
    Trials; 2023 Sep; 24(1):595. PubMed ID: 37716990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving care for critically ill patients with community-acquired pneumonia.
    Bianchini ML; Mercuro NJ; Kenney RM; Peters MA; Samuel LP; Swiderek J; Davis SL
    Am J Health Syst Pharm; 2019 Jun; 76(12):861-868. PubMed ID: 31361849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation.
    Hellyer TP; McAuley DF; Walsh TS; Anderson N; Conway Morris A; Singh S; Dark P; Roy AI; Perkins GD; McMullan R; Emerson LM; Blackwood B; Wright SE; Kefala K; O'Kane CM; Baudouin SV; Paterson RL; Rostron AJ; Agus A; Bannard-Smith J; Robin NM; Welters ID; Bassford C; Yates B; Spencer C; Laha SK; Hulme J; Bonner S; Linnett V; Sonksen J; Van Den Broeck T; Boschman G; Keenan DJ; Scott J; Allen AJ; Phair G; Parker J; Bowett SA; Simpson AJ
    Lancet Respir Med; 2020 Feb; 8(2):182-191. PubMed ID: 31810865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for ventilator-associated pneumonia.
    Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study.
    Lat I; Daley MJ; Shewale A; Pangrazzi MH; Hammond D; Olsen KM;
    Pharmacotherapy; 2019 Mar; 39(3):253-260. PubMed ID: 30101412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals.
    Catho G; Sauser J; Coray V; Da Silva S; Elzi L; Harbarth S; Kaiser L; Marti C; Meyer R; Pagnamenta F; Portela J; Prendki V; Ranzani A; Centemero NS; Stirnemann J; Valotti R; Vernaz N; Suter BW; Bernasconi E; Huttner BD;
    Lancet Infect Dis; 2022 Oct; 22(10):1493-1502. PubMed ID: 35870478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Trials; 2015 Aug; 16():355. PubMed ID: 26272324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.
    Goodman KE; Baghdadi JD; Magder LS; Heil EL; Sutherland M; Dillon R; Puzniak L; Tamma PD; Harris AD
    Clin Infect Dis; 2023 Feb; 76(3):e1224-e1235. PubMed ID: 35737945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.